Pharming (PHAR) EV to CFO (2021 - 2026)
Pharming's EV to CFO was 61.84 in Q2 2026.
Powered by 
Analysis
Pharming (PHAR) EV to CFO (2021 - 2026) Analysis & Trends
On a trailing twelve-month basis, Pharming's EV to CFO was 10.96 through Jun 30, 2026; for FY2025, it was 18.74.
- In earlier years, EV to CFO was 23.00 in FY2022 (+50.1%) and 15.32 in FY2021 (+64.3%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Pharming | 664.67 Mn | -129.70 Mn | 141.47 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 33.53 |
| Dec 31, 2025 | 25.40 |
| Jun 30, 2025 | 55.26 |
| Dec 31, 2024 | 52.80 |
| Sep 30, 2024 | 96.00 |
| Dec 31, 2022 | 20.03 |
| Sep 30, 2022 | 13.46 |
| Dec 31, 2021 | 7.47 |
API Access
Pharming EV to CFO API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=PHAR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-cfo", "ticker": "PHAR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=PHAR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();